{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:50:33Z","timestamp":1790895033835,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1 AI068961"],"award-info":[{"award-number":["RO1 AI068961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.11.079","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T15:10:23Z","timestamp":1291907423000},"page":"1248-1257","source":"Crossref","is-referenced-by-count":75,"title":["Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs"],"prefix":"10.1016","volume":"29","author":[{"given":"Xiaohong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Dalebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bredenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Goicochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Salvato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor S.","family":"Lukashevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.11.079_bib0005","series-title":"Vaccines for biodefense and emerging and neglected diseases","first-page":"753","article-title":"Yellow fever","author":"Galbraith","year":"2009"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0020","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/CVI.00369-09","article-title":"Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination","volume":"17","author":"Silva","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0045","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0050","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins M\u00c2","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins M.\u00c2.","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","article-title":"Detection of TH1\/TH2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay","volume":"42","author":"Santos","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0070","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0080","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0085","first-page":"341","article-title":"Yellow fever as an endemic\/epidemic disease and priorities for vaccination","volume":"99","author":"Monath","year":"2006","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0090","series-title":"The yellow fever initiative, 2007","author":"WHO","year":"2007"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.2001.5258","article-title":"Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus","volume":"315","author":"Bonaldo","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0105","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1128\/JVI.79.13.8602-8613.2005","article-title":"Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface","volume":"79","author":"Bonaldo","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0345","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2010.04.071","article-title":"Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii","volume":"28","author":"Stoyanov","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for field research on the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0125","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0130","first-page":"86","article-title":"Update on Lassa fever in West Africa","volume":"80","author":"Anonymous:","year":"2005","journal-title":"Weekly Epidemiol Record"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0135","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0140","doi-asserted-by":"crossref","unstructured":"Fichet-Calvet E, Rogers DJ. Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis 2009;3, doi:e38810.31371\/journal.pntd.0000388.","DOI":"10.1371\/journal.pntd.0000388"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0145","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0150","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for Lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/14760584.3.2.189","article-title":"Lassa fever vaccine","volume":"3","author":"Fisher-Hoch","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01310811","article-title":"Ribonucleic acids of Machupo and Lassa viruses","volume":"79","author":"Lukashevich","year":"1984","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/138920206778948673","article-title":"Lassa virus genome","volume":"7","author":"Lukashevich","year":"2006","journal-title":"Curr Genomics"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1099\/0022-1317-78-3-547","article-title":"The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250kDa protein with monospecific antiserum","volume":"78","author":"Lukashevich","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/viro.1997.8722","article-title":"Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5\u2032 end","volume":"235","author":"Djavani","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0042-6822(86)90438-1","article-title":"Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA","volume":"154","author":"Auperin","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0168-1702(91)90015-N","article-title":"Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products","volume":"18","author":"Clegg","year":"1991","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0190","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0195","unstructured":"Feldmann H, Geisbert TW, Jahrling PB, Klenk HD, Netesov SV, Peters CJ, et al. Filoviridae. Virus taxonomy. VIIIth report of the International Committee on Taxonomy of Viruses; 2005. p. 645\u201353."},{"key":"10.1016\/j.vaccine.2010.11.079_bib0200","first-page":"5","article-title":"Experimental studies of arenaviral hemorrhagic fevers","volume":"134","author":"Peters","year":"1987","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0205","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant yellow fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0215","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","article-title":"A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication","volume":"84","author":"Bredenbeek","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0220","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(92)90514-P","article-title":"Generation of reassortants between African arenaviruses","volume":"188","author":"Lukashevich","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0225","series-title":"Molecular pathogenesis of hemorrhagic fever viruses","first-page":"143","article-title":"A live reassortant vaccine for Lassa Fver","author":"Lukashevich","year":"2010"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0230","series-title":"Molecular pathogenesis of hemorrhagic fever viruses","first-page":"101","article-title":"Pathogenesis of Lassa virus infection in experimental animals","author":"Lukashevich","year":"2010"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0235","series-title":"New generation vaccines","first-page":"895","article-title":"Vaccines against Lassa fever","author":"Salvato","year":"2009"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0240","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0245","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/JCM.32.12.2898-2903.1994","article-title":"Early diagnosis of Lassa fever by reverse transcription-PCR","volume":"32","author":"Demby","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"Bonaldo","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0255","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4269\/ajtmh.1986.35.401","article-title":"Lassa virus hepatitis: a study of fatal Lassa fever in humans","volume":"35","author":"McCormick","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/IAI.37.2.771-778.1982","article-title":"Pathogenesis of Lassa virus infection in guinea pigs","volume":"37","author":"Jahrling","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0265","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.vaccine.2007.02.038","article-title":"A ML29 reassortant virus protects guinea pigs against a distantly-related Nigerian strain of Lassa virus and can provide sterilizing immunity","volume":"25","author":"Carrion","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0270","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.1128\/JVI.74.19.9197-9205.2000","article-title":"Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases","volume":"74","author":"McAllister","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.20042565","article-title":"Broadening the horizons for yellow fever: new uses for an old vaccine","volume":"201","author":"Van Epps","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0280","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.2001.5258","article-title":"Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus","volume":"315","author":"Bonaldo","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0285","first-page":"492","article-title":"Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector","volume":"22","author":"Xiaowu","year":"2006","journal-title":"Chin J Biotech"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0290","unstructured":"Chambers TJ, Monath TP, Guirakhoo F. US6696281; 2004."},{"key":"10.1016\/j.vaccine.2010.11.079_bib0295","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.virol.2009.10.033","article-title":"Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus","volume":"396","author":"Rumyantsev","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0300","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in Rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0310","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: A 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2005.03.009","article-title":"Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys","volume":"33","author":"Monath","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0320","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in Rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0325","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1086\/314031","article-title":"Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases","volume":"31","author":"Receveur","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0330","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00002030-200403260-00020","article-title":"Yellow fever vaccine is safe and effective in HIV-infected patients","volume":"18","author":"Tattevin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0335","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.4049\/jimmunol.0902276","article-title":"Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells","volume":"183","author":"Xiang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.11.079_bib0340","unstructured":"Zapata JCPB, Goicochea M, Bryant J, Davis H, Pauza CD, Lukashevich IS, et al. Arenavirus vaccines in SIV-positive Rhesus macaques. ASV, 28th Meeting, Scientific Program & Abstracts, Vancouver, Canada. 2009. W7-9, p. 94."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T13:15:13Z","timestamp":1592140513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10017238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10017238"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}